Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 6/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | GPR35 | Q9HC97 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28618 | 0.80 | TDP1 (0.61) | TSHRTDP1ALDH1A1MAPK1MEN1 | |
| SCHEMBL2257975 | 0.78 | MAPK1 (0.59) | TSHRTDP1ALDH1A1MAPK1POLB | |
| SCHEMBL9017796 | 0.78 | TSHR (0.60) | TSHRCYP3A4TDP1ALDH1A1MAPK1 | |
| SCHEMBL28102714 | 0.78 | CASP6 (0.37) | CASP6TSHRCYP3A4TDP1ALDH1A1 | |
| SCHEMBL12020165 | 0.78 | ALDH1A1 (0.62) | CASP6TSHRTDP1ALDH1A1MAPK1 | |
| SCHEMBL686890 | 0.78 | TDP1 (0.59) | CASP6TSHRCYP3A4TDP1ALDH1A1 | |
| SCHEMBL7341303 | 0.78 | ALDH1A1 (0.64) | TSHRCYP3A4TDP1ALDH1A1MAPK1 | |
| SCHEMBL489333 | 0.78 | S100A4 (0.49) | CASP6TSHRCYP3A4TDP1ALDH1A1 | |
| SCHEMBL6523809 | 0.78 | TSHR (0.67) | TSHRCYP3A4TDP1ALDH1A1MAPK1 | |
| SCHEMBL9073528 | 0.78 | GPR35 (0.62) | TSHRCYP3A4ALDH1A1MAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334661-B1 | PROCESSES FOR PREPARING POLY(PENTAFLUOROSULFANYL)AROMATIC COMPOUNDS | UBE INDUSTRIES (JP) | 2017-08-30 | — | — | EP | disclosed |
| US-8653302-B2 | Processes for preparing poly(pentafluorosulfanyl)aromatic compounds | UBE INDUSTRIES, LTD. (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | UBE INDUSTRIES, LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| EP-2334661-A1 | PROCESSES FOR PREPARING POLY(PENTAFLUOROSULFANYL)AROMATIC COMPOUNDS | Ube Industries, Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
| WO-2010033930-A1 | PROCESSES FOR PREPARING POLY(PENTAFLUOROSULFANYL)AROMATIC COMPOUNDS | IM&T RESEARCH, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| US-3979369-A | DIENE POLYMER | MONSANTO COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3974163-A | VULCANIZATION INHIBITOR | MONSANTO COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166392-A1 | Processes for Preparing Poly(Pentafluorosulfanyl)Aromatic Compounds | PFAS, PUF60, FES | CASP6 3028/4885TSHR 1592/4885CYP3A4 2580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.